- Home
- HUMA
HUMA
Humacyte Inc.
as of 12-17-2025 3:56pm EST
$1.08
$0.05
-4.87%
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Chart Type:
Time Range:
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 236.0M | IPO Year: | N/A |
| Target Price: | $10.13 | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.09 - $6.77 | Next Earning Date: | 11-12-2025 |
| Revenue: | $1,571,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 731.05% |
Latest Humacyte Inc. News
HUMA Breaking Stock News: Dive into HUMA Ticker-Specific Updates for Smart Investing
GlobeNewswire
Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital
📈
AI Sentiment
Highly Positive
8/10
Compare HUMA vs Leading Stocks
See how HUMA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HUMA Humacyte Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.